1 MORTALITY RISK FOR LIFE INSURERS AND …andrewc/ohp/cairns_zurich2007.pdf1 MORTALITY RISK FOR LIFE...
Transcript of 1 MORTALITY RISK FOR LIFE INSURERS AND …andrewc/ohp/cairns_zurich2007.pdf1 MORTALITY RISK FOR LIFE...
1
MORTALITY RISK FOR
LIFE INSURERS AND PENSION
FUNDS
ANDREW CAIRNS
Heriot-Watt University, Edinburgh
and
The Maxwell Institute, Edinburgh
2
PLAN FOR TALK
• Background and the mortality problem
• Possible solutions
• Stochastic mortality models
• Basis risk
• Conclusions
3
The Problem
Nothing is certain in life except death and taxes.
(1789: Franklin)
2005: What we know as the facts:
• Death is still a certainty!
• Life expectancy is increasing.
• Future development of life expectancy is uncertain.
“Longevity risk”
4
The Problem: Insurance risk
• Traditional view:
Pooling of insurance risks⇒ diversification
BUT
• Systematic risks: e.g.
– Florida hurricane risk
– Pandemic risk
– Long-term mortality improvements
5
The Problem – UK Defined-Benefit Pension Plans:
• Before 2000:
– High equity returns masked impact of longevity
improvements
• After 2000:
– Poor equity returns, low interest rates
– Decades of longevity improvements now a problem
6
The Problem – Life Insurers: annuity business
• Annuity providers:
– Risk due to unanticipated improvements in mortality.
• Equitable Life (and others): GAO’s
Guaranteed Annuity Option: becomes valuable if
– interest rates fall
– mortality rates fall
7
The Problem – Life Insurers: life business
• Short-term catastrophes
– Pandemic
– Terrorism
– Earthquake etc.
• Long-term, unanticipated deterioration in mortality
8
Insurers: What to do with systematic mortality risk?
• Ignore – risk not significant;
• Accept as a legitimate business risk;
• Diversify insurance liabilities (annuities + life);
• Replace fixed annuities with participating contracts;
• Reinsurance (downside risk);
• Securitise a line of business;
• OTC mortality-linked contracts;
• Traded mortality-linked securities.
9
Pension plans: What to do with systematic mortality risk?
• Cannot/should not:
– Ignore; Accept as business risk; Diversify.
• Purchase individual annuities from insurer;
• Bulk buyout;
• Actively manage risk using:
– OTC mortality-linked contracts;
– traded mortality-linked securities.
10
Life insurer’s perspective
1900 1920 1940 1960 1980 2000
−7.
5−
6.5
−5.
5−
4.5
England and Wales: Males age 20−29 mortality
Year
log
Mor
talit
y ra
te
Spanish flu
WW II
AIDS
11
England and Wales log mortality rates 1950-2002
1950 1960 1970 1980 1990 2000
−5.
0−
4.8
−4.
6−
4.4
−4.
2−
4.0
−3.
8−
3.6
Year
log(
mor
talit
y )
Age 60
1950 1960 1970 1980 1990 2000
−3.
0−
2.8
−2.
6−
2.4
−2.
2−
2.0
−1.
8−
1.6
Year
log(
mor
talit
y )
Age 80
12
Why do we need stochastic mortality models?
Data⇒ future mortality is uncertain
• Good risk management
• Setting risk reserves
• Life insurance contracts with embedded options
• Pricing and hedging mortality-linked securities
13
The wider picture
Life insurers and pension funds exposed to many risks
A: investment risk
B: interest-rate risk
C: mortality and longevity risk
A, B→ can hedge to reduce risk; C?
Blake, Cairns & Dowd (2006) Living with mortality ... British Actuarial Journal 12: 153-197.
14
Stochastic mortality
• Many models to choose from
• Annual mortality data
– National data; subpopulations
• Limited data⇒ model and parameter risk
15
How to compare stochastic models (*)
• Quantitative criteria
• Qualitative criteria
– parsimony and transparency
– robust relative to age and period range
– biologically reasonable
– forecasts are reasonable
(*) Cairns et al. (2007) A quantitative comparison of stochastic mortality models.... Online: www.lifemetrics.com
16
Fan charts + A plausible set of forecasts
1960 1980 2000 2020 2040
0.00
50.
020
0.05
00.
200
AGE 65
AGE 75
AGE 85
Year, t
Mor
talit
y ra
te, q
(t,x
)
Model M7 Fan Chart
AGE 65
AGE 75
AGE 85
Year, t
Mor
talit
y ra
te, q
(t,x
)
Model M7 Fan Chart
AGE 65
AGE 75
AGE 85
Year, t
Mor
talit
y ra
te, q
(t,x
)
Model M7 Fan Chart
17
Model risk
1960 1980 2000 2020 2040
0.00
50.
010
0.02
00.
050
0.10
00.
200
AGE 65
AGE 75
AGE 85
Year, t
Mor
talit
y ra
te, q
(t,x
)
Model M5 Fan Chart
18
Model risk
1960 1980 2000 2020 2040
0.00
50.
010
0.02
00.
050
0.10
00.
200
AGE 65
AGE 75
AGE 85
Year, t
Mor
talit
y ra
te, q
(t,x
)
Combined M5, M7 Fan Chart
19
Model risk
1960 1980 2000 2020 2040
0.00
50.
010
0.02
00.
050
0.10
00.
200
AGE 65
AGE 75
AGE 85
Year, t
Mor
talit
y ra
te, q
(t,x
)
Combined M5, M7, M8A Fan Chart
20
Model M2 Forecast robustness problems
1960 1980 2000 2020 2040
0.00
50.
020
0.05
00.
200
1961−2004 data: M2B full1961−2004 data: M2B limited1981−2004 data: M2B
Model M2B (ARIMA(1,1,0)) projections
Year of birth
Coh
ort e
ffect
x=65
x=75
x=85
21
Modelling Conclusions
• Be aware of model and parameter risk
• Use a full range of quantitative and qualitative criteria
Uses include:
• Risk assessment and pricing of mortality-linked
securities
22
MORTALITY-LINKED SECURITIES
• Short-term catastrophe bonds (Swiss Re, 2003, 2005)
• Survivor swaps (some OTC contracts)
swap fixed for floating mortality-linked cashflows
• Long-term longevity bonds (EIB/BNP, Nov. 2004)
cashflows linked to survivorship index
ultimately unsuccessful
23
What makes a proposed security successful?
• Attractive capital structure for hedgers
• Transparent and trustworthy underlying index
• Low basis risk for hedgers
• Good understanding of the risks being traded
⇒ need a good model
• Need receivers of longevity risk
⇒ natural hedgers; hedge funds etc.
24
November 2004: EIB/BNP Paribas longevity bond
• Payments linked to survivor index S(t)
• S(t) = proportion of cohort age 65 at time 0 surviving
to time t.
• Bond pays 50M×S(t) at time t
• Reference population: England and Wales, males
• Issuer=European Investment Bank
• Structurer and Manager=BNP Paribas
25
BNP Paribas / EIB Bond
European Investment Bank = Issuer
BNP Paribas = Manager and Structurer
EIB-
¾Bond Holders
t = 1, 2, . . . , 25
S(t)×50M
t = 0:Issue Price∼ $540M
S(t) = proportion still alive at t out of
males aged 65 in 2003
26
EIB’s perspective
• Likes to issue floating-rate notes in Euros
• Does not like floating-mortality bonds in GBP
27
EIB
Bond Holders
BNP
Partner Re
¾
Issue Price
?
¾
Survivor Swap
Issue Price
-¾Interest-rate swap
6Floating S(t)
+ Credit Insurance ???
28
0 5 10 15 20 25
0.0
0.2
0.4
0.6
0.8
1.0
Time, t
S(t
)
Longevity bond coupon payments
E[S(t)] without parameter uncertainty5/95−percentile with parameter uncertainty
• Too much capital up front for limited risk transfer
• Perceived basis risk
• Price not obviously a problem
29
What still needs to be done?
Longevity-linked securities:
• Right capital structure
– Survivor swaps (standardised?)
– Survivor caps and caplets
– Capital-at-risk bonds
• Need to understand basis risk
30
Traded securities: basis risk
Basis Risk⇒mismatch between reference population and own risk
Examples:
• different population characteristics
• different age profile
• males/females
31
Traded securities: basis risk
Single, reliable reference population
⇒ high basis risk for many hedgers
⇒ security not worth holding
⇒ low demand
⇒ low liquidity
32
Traded securities: basis risk
Several reference populations
⇒ low basis risk for hedgers
BUT too many reference populations
⇒ poor transparancy or reliability
⇒ low liquidity
Tradeoff required to get the right balance
33
Basis risk
• More work to be done
• Relatively little data
⇒ need to work hard to extract stylised facts
• Role for biological reasonableness
34
Conclusions
• Life Insurance and Pensions liabilities are huge
($ Trillions)
• Life insurers and pension plans are exposed to
significant systematic longevity risk
• Options:
– bear the risk internally
– transfer the risk to the financial markets
35
Conclusions
• Requirement for good risk management⇒ Potential huge demand for mortality-linked
securities
• Challenges for the future:
– to improve statistical models;
– to develop a substantial, liquid market in
mortality-linked securities
⇒ need to design products that are attractive forboth buyers and sellers
36
Andrew Cairns
Department of Actuarial Mathematics and Statistics
Heriot-Watt University
Edinburgh, EH14 4AS, UK
E-mail: [email protected]
WWW: http://www.ma.hw.ac.uk/∼andrewc